Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-04-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 28,00 | 698,68 | Acquisition Under Employee Benefit Plan | 24,95 | 6,77k | 0,42% |
| 2026-04-15 | Mr. Paul GalbraithExec. VP & MD of USA | 142,00 | 3,54k | Acquisition Under Employee Benefit Plan | 24,95 | 5,84k | 2,49% |
| 2026-04-15 | Mr. Don BirdInsider | 169,00 | 4,22k | Acquisition Under Employee Benefit Plan | 24,95 | 20,60k | 0,83% |
| 2026-03-13 | Mr. John DohertyChief Science & Innovation Officer | 9,42k | 239,95k | Kauf | 25,47 | 20,48k | 85,16% |
| 2026-03-10 | Ms. Diane NyisztorIndependent Director | 1,76k | 45,97k | Derivative Exercise and Retained Stock | 26,13 | 1,25k | -345,58% |
| 2026-03-10 | Ms. Diane NyisztorIndependent Director | -509,00 | 13,30k | Verkauf | 26,13 | 1,25k | -28,94% |
| 2026-03-10 | Dr. Louis J. AronneMember of the Scientific Advisory Board & Director | 2,11k | 55,16k | Derivative Exercise and Retained Stock | 26,13 | 11,48k | 22,54% |
| 2026-03-10 | Dr. Louis J. AronneMember of the Scientific Advisory Board & Director | -633,00 | 16,54k | Verkauf | 26,13 | 11,48k | -5,23% |
| 2026-03-09 | Mr. Christopher SnowdenCFO | 29,21k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 169,32k | 20,85% |
| 2026-03-09 | Ms. Regan StewartCOO | 26,64k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 209,27k | 14,58% |
| 2026-03-09 | Mr. Michael PilatoPresident, CEO & Director | 86,38k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 565,60k | 18,02% |
| 2026-03-09 | Mr. John DohertyChief Science & Innovation Officer | 36,87k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 223,38k | 19,77% |
| 2026-03-09 | Mr. Paul GalbraithExec. VP & MD of USA | 15,45k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 95,16k | 19,38% |
| 2026-03-09 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 15,13k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 91,48k | 19,82% |
| 2026-03-09 | Mr. Eric BentzExec. VP of Global Marketing & MD of Canada | 15,00k | 0,00 | Derivative Acquisition Under Employee Benefit Plan | 26,89 | 67,16k | 28,76% |
| 2026-03-05 | Mr. Christopher SnowdenCFO | -18,38k | 5,07k | Derivative Exercise and Sale | 25,84 - 26,12 | 172,02k | - |
| 2026-03-05 | Ms. Regan StewartCOO | 18,38k | 474,88k | Derivative Exercise and Retained Stock | 25,84 | 35,41k | 107,90% |
| 2026-03-09 | Ms. Regan StewartCOO | -9,84k | 256,92k | Verkauf | 26,12 | 35,41k | -21,74% |
| 2026-03-05 | Mr. John DohertyChief Science & Innovation Officer | -14,12k | 3,90k | Derivative Exercise and Sale | 25,84 - 26,12 | 15,77k | - |
| 2026-03-05 | Mr. Don BirdInsider | -14,12k | 3,90k | Derivative Exercise and Sale | 25,84 - 26,12 | 20,43k | - |
| 2026-03-05 | Mr. Paul GalbraithExec. VP & MD of USA | -10,08k | 2,78k | Derivative Exercise and Sale | 25,84 - 26,12 | 5,69k | - |
| 2026-03-05 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | -11,59k | 3,20k | Derivative Exercise and Sale | 25,84 - 26,12 | 6,74k | - |
| 2026-03-05 | Mr. Eric BentzExec. VP of Global Marketing & MD of Canada | 4,37k | 112,99k | Derivative Exercise and Retained Stock | 25,84 | 5,13k | 577,54% |
| 2026-03-05 | Mr. Eric BentzExec. VP of Global Marketing & MD of Canada | -5,04k | 1,39k | Derivative Exercise and Sale | 25,84 - 26,12 | 5,13k | - |
| 2026-03-05 | Mr. Michael PilatoPresident, CEO & Director | 24,61k | 636,04k | Derivative Exercise and Retained Stock | 25,84 | 82,35k | 42,62% |
| 2026-03-05 | Mr. Michael PilatoPresident, CEO & Director | -28,35k | 7,83k | Derivative Exercise and Sale | 25,84 - 26,12 | 82,35k | - |
| 2026-01-15 | Mr. Don BirdInsider | 197,00 | 4,88k | Acquisition Under Employee Benefit Plan | 24,77 | 20,43k | 0,97% |
| 2026-01-15 | Mr. Paul GalbraithExec. VP & MD of USA | 165,00 | 4,09k | Acquisition Under Employee Benefit Plan | 24,77 | 5,69k | 2,98% |
| 2026-01-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 32,00 | 792,77 | Acquisition Under Employee Benefit Plan | 24,77 | 6,74k | 0,48% |
| 2025-10-15 | Mr. Don BirdInsider | 195,00 | 4,83k | Acquisition Under Employee Benefit Plan | 24,76 | 20,24k | 0,97% |
| 2025-10-15 | Mr. Paul GalbraithExec. VP & MD of USA | 163,00 | 4,04k | Acquisition Under Employee Benefit Plan | 24,76 | 5,53k | 3,04% |
| 2025-10-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 32,00 | 792,38 | Acquisition Under Employee Benefit Plan | 24,76 | 6,71k | 0,48% |
| 2025-09-11 | Ms. Regan StewartCOO | -12,20k | 187,46k | Derivative Exercise and Sale | 11,38 - 26,75 | 26,87k | - |
| 2025-09-15 | Mr. Michael PilatoPresident, CEO & Director | -24,08k | 196,25k | Derivative Exercise and Sale | 18,65 - 26,80 | 57,74k | - |
| 2025-09-05 | Ms. Regan StewartCOO | -9,10k | 140,22k | Derivative Exercise and Sale | 11,39 - 26,80 | 26,87k | - |
| 2025-08-12 | Mr. Christopher SnowdenCFO | 122,05k | 1,85M | Derivative Exercise and Retained Stock | 11,45 - 18,90 | 172,02k | 244,24% |
| 2025-08-19 | Mr. Christopher SnowdenCFO | -106,85k | 2,78M | Verkauf | 26,01 | 172,02k | -38,32% |
| 2025-08-26 | Mr. Paul GalbraithExec. VP & MD of USA | -7,91k | 61,44k | Derivative Exercise and Sale | 18,62 - 26,40 | 5,37k | - |
| 2025-08-19 | Ms. Regan StewartCOO | -12,50k | 184,78k | Derivative Exercise and Sale | 11,36 - 26,29 | 26,87k | - |
| 2025-08-20 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | -6,49k | 50,07k | Derivative Exercise and Sale | 18,58 - 26,29 | 6,68k | - |
| 2025-08-12 | Mr. John DohertyChief Science & Innovation Officer | -25,44k | 207,61k | Derivative Exercise and Sale | 18,72 - 26,88 | 15,77k | - |
| 2025-08-13 | Mr. Don BirdInsider | -27,13k | 224,38k | Derivative Exercise and Sale | 18,70 - 26,97 | 20,04k | - |
| 2025-07-15 | Mr. Don BirdInsider | 166,00 | 4,24k | Acquisition Under Employee Benefit Plan | 25,53 | 20,04k | 0,84% |
| 2025-07-15 | Mr. Paul GalbraithExec. VP & MD of USA | 139,00 | 3,55k | Acquisition Under Employee Benefit Plan | 25,53 | 5,37k | 2,66% |
| 2025-07-15 | Mr. Joel ScalesExec. VP and MD of Jamieson International & Global Strategy | 27,00 | 689,43 | Acquisition Under Employee Benefit Plan | 25,53 | 6,68k | 0,41% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
